“When you drop any new idea in the pond of the world, you get a ripple effect. You have to be aware that you will be creating a cascade of change.”

– Joel A. Barker
“When you drop any new idea in the pond of the world, you get a ripple effect. You have to be aware that you will be creating a cascade of change.”

– Joel A. Barker
“The key is to embrace disruption and change early. Don’t react to it decades later.”

- Ryan Kavanaugh
“The key is to embrace disruption and change early. Don’t react to it decades later.”

- Ryan Kavanaugh
“Do not go where the path may lead, go instead where there is no path and leave a trail.”

– Ralph Waldo Emerson
“Do not go where the path may lead, go instead where there is no path and leave a trail.”

– Ralph Waldo Emerson
“This is the age of disruption.”

– Sebastian Thrun
“This is the age of disruption.”

– Sebastian Thrun

Instead of “running with the herd” to develop therapeutics that treat the advanced stages and symptoms of autoimmune and inflammatory diseases after they’ve emerged, Provention Bio is taking a path less travelled, by pre-empting, slowing and reversing the progression of chronic diseases and developing technologies that intervene before the targeted disease begins, re-appears or progresses.

about provention bio

Provention Bio, Inc. is a clinical stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics and cutting edge solutions to intercept and prevent immune-mediated disease.

more about provention bio >

leadership

Ashleigh Palmer

Ashleigh Palmer

Chief Executive Officer & Co-Founder read bio >
Eleanor L. Ramos, MD

Eleanor L. Ramos, MD

Chief Medical Officer & Chief Operating Officer read bio >
Francisco Leon, M.D., Ph.D.

Francisco Leon, M.D., Ph.D.

Scientific Co-Founder read bio >

therapeutic mission

Provention Bio’s strategy is to develop and commercialize novel agents, therapeutics and cutting edge solutions to intercept and prevent immune-mediated disease. We foresee substantial opportunity to pre-empt, slow and reverse the progression of a variety of chronic immune-mediated and inflammatory diseases by identifying and targeting at-risk individuals, focusing on potential pre-disease states, and developing “upstream” mechanisms of action.

more therapeutic mission >

news & resources

PRIVATE EQUITY-LIKE FUND AIMS TO SPEED UP DIABETES RESEARCH

THE NEW YORK TIMES


see all news articles >


PROVENTION BIO, INC. ANNOUNCES CLINICAL PROGRAM FOCUSED ON INTERCEPTING AND PREVENTING THE ONSET OF TYPE 1 DIABETES


see press releases >

contact us

For more information: call 908.336.0360 or email: info@proventionbio.com